Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Importance of Participant-Centricity and Trust for a Sustainable Medical Information Commons.

McGuire AL, Majumder MA, Villanueva AG, Bardill J, Bollinger JM, Boerwinkle E, Bubela T, Deverka PA, Evans BJ, Garrison NA, Glazer D, Goldstein MM, Greely HT, Kahn SD, Knoppers BM, Koenig BA, Lambright JM, Mattison JE, O'Donnell C, Rai AK, Rodriguez LL, Simoncelli T, Terry SF, Thorogood AM, Watson MS, Wilbanks JT, Cook-Deegan R.

J Law Med Ethics. 2019 Mar;47(1):12-20. doi: 10.1177/1073110519840480.

PMID:
30994067
2.

Add Water and Serve: Liquid Biopsies Making Waves.

Terry SF.

Genet Test Mol Biomarkers. 2019 Apr;23(4):233-234. doi: 10.1089/gtmb.2019.29045.sjt. Epub 2019 Mar 28. No abstract available.

PMID:
30920323
3.

Magnesium supplementation in the treatment of pseudoxanthoma elasticum: A randomized trial.

Rose S, On SJ, Fuchs W, Chen C, Phelps R, Kornreich D, Haddican M, Singer G, Wong V, Baum D, Vekaria A, Gagliotti M, Huang R, Suárez-Fariñas M, Terry SF, Lebwohl M.

J Am Acad Dermatol. 2019 Jul;81(1):263-265. doi: 10.1016/j.jaad.2019.02.055. Epub 2019 Feb 28. No abstract available.

PMID:
30826287
4.

A Role for Storytelling in Improving Consumer Understanding of Genetic Testing.

Terry SF, Westreich AM.

Genet Test Mol Biomarkers. 2019 Jan;23(1):1-2. doi: 10.1089/gtmb.2018.29041.sjt. Epub 2018 Dec 28. No abstract available.

PMID:
30592631
5.

CRISPR-Cas9: New Heights, New Hesitations.

Rich K, Terry SF.

Genet Test Mol Biomarkers. 2018 Nov;22(11):635-636. doi: 10.1089/gtmb.2018.0267. Epub 2018 Nov 15. No abstract available.

PMID:
30452298
6.

To Test or Not to Test?

Terry SF.

Genet Test Mol Biomarkers. 2018 Oct;22(10):583-584. doi: 10.1089/gtmb.2018.0254. No abstract available.

PMID:
30339502
7.

Newborn Screening and Health Communications.

Evans A, Bonhomme N, Goodman A, Terry SF.

Genet Test Mol Biomarkers. 2018 Sep;22(9):507-508. doi: 10.1089/gtmb.2018.0234. No abstract available.

PMID:
30235037
8.

Reuniting Families Using Genetic Testing?

Oliphant EN, Terry SF.

Genet Test Mol Biomarkers. 2018 Aug;22(8):453-455. doi: 10.1089/gtmb.2018.0201. No abstract available.

PMID:
30117776
9.

The Price of Precision: Genetic Testing and Drug Costs in America.

Rich K, Terry SF.

Genet Test Mol Biomarkers. 2018 Jul;22(7):403-404. doi: 10.1089/gtmb.2018.0169. No abstract available.

PMID:
30020834
10.

Plain-language medical vocabulary for precision diagnosis.

Vasilevsky NA, Foster ED, Engelstad ME, Carmody L, Might M, Chambers C, Dawkins HJS, Lewis J, Della Rocca MG, Snyder M, Boerkoel CF, Rath A, Terry SF, Kent A, Searle B, Baynam G, Jones E, Gavin P, Bamshad M, Chong J, Groza T, Adams D, Resnick AC, Heath AP, Mungall C, Holm IA, Rageth K, Brownstein CA, Shefchek K, McMurry JA, Robinson PN, Köhler S, Haendel MA.

Nat Genet. 2018 Apr;50(4):474-476. doi: 10.1038/s41588-018-0096-x. No abstract available.

11.

Beyond Recommendation: Requiring Returning Findings to Research Participants.

Wurst T, Terry SF.

Genet Test Mol Biomarkers. 2018 Mar;22(3):141-142. doi: 10.1089/gtmb.2018.0052. No abstract available.

PMID:
29565740
12.

Including all voices in international data-sharing governance.

Kaye J, Terry SF, Juengst E, Coy S, Harris JR, Chalmers D, Dove ES, Budin-Ljøsne I, Adebamowo C, Ogbe E, Bezuidenhout L, Morrison M, Minion JT, Murtagh MJ, Minari J, Teare H, Isasi R, Kato K, Rial-Sebbag E, Marshall P, Koenig B, Cambon-Thomsen A.

Hum Genomics. 2018 Mar 7;12(1):13. doi: 10.1186/s40246-018-0143-9.

13.

Application of a Dynamic Map for Learning, Communicating, Navigating, and Improving Therapeutic Development.

Wagner JA, Dahlem AM, Hudson LD, Terry SF, Altman RB, Gilliland CT, DeFeo C, Austin CP.

Clin Transl Sci. 2018 Mar;11(2):166-174. doi: 10.1111/cts.12531. Epub 2017 Dec 22.

14.

A dynamic map for learning, communicating, navigating and improving therapeutic development.

Wagner J, Dahlem AM, Hudson LD, Terry SF, Altman RB, Gilliland CT, DeFeo C, Austin CP.

Nat Rev Drug Discov. 2018 Feb;17(2):150. doi: 10.1038/nrd.2017.217. Epub 2017 Dec 22. No abstract available.

PMID:
29269942
15.

Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.

Baynam G, Bowman F, Lister K, Walker CE, Pachter N, Goldblatt J, Boycott KM, Gahl WA, Kosaki K, Adachi T, Ishii K, Mahede T, McKenzie F, Townshend S, Slee J, Kiraly-Borri C, Vasudevan A, Hawkins A, Broley S, Schofield L, Verhoef H, Groza T, Zankl A, Robinson PN, Haendel M, Brudno M, Mattick JS, Dinger ME, Roscioli T, Cowley MJ, Olry A, Hanauer M, Alkuraya FS, Taruscio D, Posada de la Paz M, Lochmüller H, Bushby K, Thompson R, Hedley V, Lasko P, Mina K, Beilby J, Tifft C, Davis M, Laing NG, Julkowska D, Le Cam Y, Terry SF, Kaufmann P, Eerola I, Norstedt I, Rath A, Suematsu M, Groft SC, Austin CP, Draghia-Akli R, Weeramanthri TS, Molster C, Dawkins HJS.

Adv Exp Med Biol. 2017;1031:55-94. doi: 10.1007/978-3-319-67144-4_4. Review.

PMID:
29214566
16.

A Crack in the Wall of Competition: Will Compassion Prevail?

Terry SF.

Genet Test Mol Biomarkers. 2017 Nov;21(11):635-636. doi: 10.1089/gtmb.2017.29037.sjt. No abstract available.

PMID:
29154720
17.

The International Rare Diseases Research Consortium Announces New Vision and Goals.

Terry SF.

Genet Test Mol Biomarkers. 2017 Oct;21(10):578-579. doi: 10.1089/gtmb.2017.29035.sjt. No abstract available.

PMID:
29045173
18.

Creating a data resource: what will it take to build a medical information commons?

Deverka PA, Majumder MA, Villanueva AG, Anderson M, Bakker AC, Bardill J, Boerwinkle E, Bubela T, Evans BJ, Garrison NA, Gibbs RA, Gentleman R, Glazer D, Goldstein MM, Greely H, Harris C, Knoppers BM, Koenig BA, Kohane IS, La Rosa S, Mattison J, O'Donnell CJ, Rai AK, Rehm HL, Rodriguez LL, Shelton R, Simoncelli T, Terry SF, Watson MS, Wilbanks J, Cook-Deegan R, McGuire AL.

Genome Med. 2017 Sep 22;9(1):84. doi: 10.1186/s13073-017-0476-3.

19.

Research for the People by the People.

Terry SF.

Genet Test Mol Biomarkers. 2017 Sep;21(9):521-522. No abstract available.

PMID:
28915083
20.

Future of Rare Diseases Research 2017-2027: An IRDiRC Perspective.

Austin CP, Cutillo CM, Lau LPL, Jonker AH, Rath A, Julkowska D, Thomson D, Terry SF, de Montleau B, Ardigò D, Hivert V, Boycott KM, Baynam G, Kaufmann P, Taruscio D, Lochmüller H, Suematsu M, Incerti C, Draghia-Akli R, Norstedt I, Wang L, Dawkins HJS; International Rare Diseases Research Consortium (IRDiRC).

Clin Transl Sci. 2018 Jan;11(1):21-27. doi: 10.1111/cts.12500. Epub 2017 Oct 23. Review. No abstract available.

21.

An Evidence Framework for Genetic Testing.

Terry SF.

Genet Test Mol Biomarkers. 2017 Jul;21(7):407-408. doi: 10.1089/gtmb.2017.29032.sjt. No abstract available.

PMID:
28715288
22.

A New Day Dawns for Direct-to-Consumer Marketing.

Mena C, Terry SF.

Genet Test Mol Biomarkers. 2017 May;21(5):273-274. doi: 10.1089/gtmb.2017.29031.sjt. No abstract available.

PMID:
28498774
23.

Insights into Pathomechanisms and Treatment Development in Heritable Ectopic Mineralization Disorders: Summary of the PXE International Biennial Research Symposium-2016.

Uitto J, Li Q, van de Wetering K, Váradi A, Terry SF.

J Invest Dermatol. 2017 Apr;137(4):790-795. doi: 10.1016/j.jid.2016.12.014. Review.

24.

Turning Toward Participants in Biobanking.

Terry SF.

Genet Test Mol Biomarkers. 2017 Mar;21(3):132-133. doi: 10.1089/gtmb.2017.29029.sjt. No abstract available.

PMID:
28306400
25.

Data Sharing as the New Norm: What About the People Part?

Lambertson KF, Terry SF.

Genet Test Mol Biomarkers. 2017 Feb;21(2):63-65. doi: 10.1089/gtmb.2017.29026.sjt. No abstract available.

PMID:
28207325
26.

PhenX measures for phenotyping rare genetic conditions.

Phillips M, Grant T, Giampietro P, Bodurtha J, Valdez R, Maiese DR, Hendershot T, Terry SF, Hamilton CM.

Genet Med. 2017 Jul;19(7):834-837. doi: 10.1038/gim.2016.199. Epub 2017 Jan 12.

27.

The study is open: Participants are now recruiting investigators.

Terry SF.

Sci Transl Med. 2017 Jan 4;9(371). pii: eaaf1001. doi: 10.1126/scitranslmed.aaf1001.

PMID:
28053150
28.

Expanded Carrier Screening and Its Implications on Genetic Testing Protocols.

Gates A, Terry SF, Bonhomme N.

Genet Test Mol Biomarkers. 2016 Nov;20(11):643-644. No abstract available.

PMID:
27831818
29.

Data Acquisition, Curation, and Use for a Continuously Learning Health System.

Krumholz HM, Terry SF, Waldstreicher J.

JAMA. 2016 Oct 25;316(16):1669-1670. doi: 10.1001/jama.2016.12537. No abstract available.

PMID:
27668668
30.

Future of Microbiomes Through the National Microbiome Initiative.

Johnson-King B, Terry SF.

Genet Test Mol Biomarkers. 2016 Oct;20(10):561-562. Review. No abstract available.

PMID:
27749134
31.

Epigenetics and Racial Health Inequities.

Oyama S, Terry SF.

Genet Test Mol Biomarkers. 2016 Sep;20(9):483-4. doi: 10.1089/gtmb.2016.29021.sjt. No abstract available.

PMID:
27636025
32.

Clinical trial result reporting: Time to move into the 21st century.

Terry SF.

Clin Trials. 2016 Dec;13(6):597-598. Epub 2016 Aug 29. No abstract available.

PMID:
27573635
33.

Rising Concern Regarding Pregnant Women and Zika Virus.

Muller M, Terry SF.

Genet Test Mol Biomarkers. 2016 Aug;20(8):411-2. doi: 10.1089/gtmb.2016.29018.sjt. Epub 2016 Jul 14. No abstract available.

PMID:
27414192
34.

GINA and ADA: New Rule Seriously Dents Previous Protections.

Oliphant EN, Terry SF.

Genet Test Mol Biomarkers. 2016 Jul;20(7):339-40. doi: 10.1089/gtmb.2016.29017.sjt. Epub 2016 Jun 23. No abstract available.

PMID:
27336709
35.

Bipartisan Genetic Research Privacy Protection Act Introduced.

Terry SF.

Genet Test Mol Biomarkers. 2016 Jun;20(6):274-5. doi: 10.1089/gtmb.2016.29016.sjt. No abstract available.

36.

Governance Through Privacy, Fairness, and Respect for Individuals.

Baker DB, Kaye J, Terry SF.

EGEMS (Wash DC). 2016 Mar 31;4(2):1207. doi: 10.13063/2327-9214.1207. eCollection 2016.

37.

New Institute of Medicine Report on Molecular Biomarkers.

Terry SF.

Genet Test Mol Biomarkers. 2016 May;20(5):221-2. doi: 10.1089/gtmb.2016.29014.sjt. Epub 2016 Apr 14. No abstract available.

PMID:
27077401
38.

Realizing Our Potential in Biobanking: Disease Advocacy Organizations Enliven Translational Research.

Edwards KA, Terry SF, Gold D, Horn EJ, Schwartz M, Stuart M, Vernon SD.

Biopreserv Biobank. 2016 Aug;14(4):314-8. doi: 10.1089/bio.2015.0053. Epub 2016 Apr 8.

39.

Life as a numerator: Putting the person in personal genomics.

Terry SF.

Appl Transl Genom. 2016 Feb 1;8:40-1. doi: 10.1016/j.atg.2016.01.007. eCollection 2016 Mar. No abstract available.

40.

The Day the President of the United States Said "That Data is Mine".

Terry SF.

Genet Test Mol Biomarkers. 2016 Apr;20(4):165-6. doi: 10.1089/gtmb.2016.29013.sjt. Epub 2016 Mar 22. No abstract available.

PMID:
27003240
41.

Research Progress in Pseudoxanthoma Elasticum and Related Ectopic Mineralization Disorders.

Li Q, Arányi T, Váradi A, Terry SF, Uitto J.

J Invest Dermatol. 2016 Mar;136(3):550-556. doi: 10.1016/j.jid.2015.10.065. Review.

42.

Genetic Testing and the Workplace.

Lambertson K, Terry SF.

Genet Test Mol Biomarkers. 2016 Mar;20(3):103-4. doi: 10.1089/gtmb.2016.29011.sjt. Epub 2016 Feb 19. No abstract available.

PMID:
26894829
43.

To Pay or Not to Pay? Is that the Question?

Terry PF, Terry SF.

Genet Test Mol Biomarkers. 2016 Feb;20(2):53-4. doi: 10.1089/gtmb.2016.29010.sjt. Epub 2016 Jan 28. No abstract available.

PMID:
26859258
44.

Toward clinical genomics in everyday medicine: perspectives and recommendations.

Delaney SK, Hultner ML, Jacob HJ, Ledbetter DH, McCarthy JJ, Ball M, Beckman KB, Belmont JW, Bloss CS, Christman MF, Cosgrove A, Damiani SA, Danis T, Delledonne M, Dougherty MJ, Dudley JT, Faucett WA, Friedman JR, Haase DH, Hays TS, Heilsberg S, Huber J, Kaminsky L, Ledbetter N, Lee WH, Levin E, Libiger O, Linderman M, Love RL, Magnus DC, Martland A, McClure SL, Megill SE, Messier H, Nussbaum RL, Palaniappan L, Patay BA, Popovich BW, Quackenbush J, Savant MJ, Su MM, Terry SF, Tucker S, Wong WT, Green RC.

Expert Rev Mol Diagn. 2016;16(5):521-32. doi: 10.1586/14737159.2016.1146593. Epub 2016 Feb 24.

45.

Benefits and Risks of Sharing Genomic Information.

Balaji D, Terry SF.

Genet Test Mol Biomarkers. 2015 Dec;19(12):648-9. doi: 10.1089/gtmb.2015.29008.sjt. Epub 2015 Nov 20. Review. No abstract available.

46.

Hearing voices: FDA seeks advice from patients.

Terry SF, Patrick-Lake B.

Sci Transl Med. 2015 Nov 11;7(313):313ed12. doi: 10.1126/scitranslmed.aad5866. No abstract available.

PMID:
26560354
47.

NIST RM 8398: Standardizing Discoveries.

Lutins E, Terry SF.

Genet Test Mol Biomarkers. 2015 Nov;19(11):589-90. doi: 10.1089/gtmb.2015.29006.sjt. Epub 2015 Oct 26. No abstract available.

48.

21st-Century Healthcare Policy and the Regulation of Laboratory-Developed Tests.

Caldwell L, Terry SF.

Genet Test Mol Biomarkers. 2015 Sep;19(9):467-8. doi: 10.1089/gtmb.2015.29004.ljc. No abstract available.

PMID:
26368293
49.

The Matchmaker Exchange: a platform for rare disease gene discovery.

Philippakis AA, Azzariti DR, Beltran S, Brookes AJ, Brownstein CA, Brudno M, Brunner HG, Buske OJ, Carey K, Doll C, Dumitriu S, Dyke SO, den Dunnen JT, Firth HV, Gibbs RA, Girdea M, Gonzalez M, Haendel MA, Hamosh A, Holm IA, Huang L, Hurles ME, Hutton B, Krier JB, Misyura A, Mungall CJ, Paschall J, Paten B, Robinson PN, Schiettecatte F, Sobreira NL, Swaminathan GJ, Taschner PE, Terry SF, Washington NL, Züchner S, Boycott KM, Rehm HL.

Hum Mutat. 2015 Oct;36(10):915-21. doi: 10.1002/humu.22858.

50.

Participant-driven matchmaking in the genomic era.

Lambertson KF, Damiani SA, Might M, Shelton R, Terry SF.

Hum Mutat. 2015 Oct;36(10):965-73. doi: 10.1002/humu.22852. Epub 2015 Aug 27.

PMID:
26252162

Supplemental Content

Loading ...
Support Center